Literature DB >> 33838745

Chemokines and the immune response to cancer.

Aleksandra J Ozga1, Melvyn T Chow1, Andrew D Luster2.   

Abstract

Chemokines are chemotactic cytokines that regulate the migration of immune cells. Chemokines function as cues for the coordinated recruitment of immune cells into and out of tissue and also guide the spatial organization and cellular interactions of immune cells within tissues. Chemokines are critical in directing immune cell migration necessary to mount and then deliver an effective anti-tumor immune response; however, chemokines also participate in the generation and recruitment of immune cells that contribute to a pro-tumorigenic microenvironment. Here, we review the role of the chemokine system in anti-tumor and pro-tumor immune responses and discuss how malignant cells and the tumor microenvironment regulate the overall chemokine landscape to shape the type and outcome of immune responses to cancer and cancer treatment.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33838745      PMCID: PMC8434759          DOI: 10.1016/j.immuni.2021.01.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  142 in total

1.  The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.

Authors:  Chun-Yang Zhang; Yu Qi; Xiang-Nan Li; Yang Yang; Dong-Lei Liu; Jia Zhao; Deng-Yan Zhu; Kai Wu; Xu-Dong Zhou; Song Zhao
Journal:  Biomed Pharmacother       Date:  2014-12-12       Impact factor: 6.529

2.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

3.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

4.  Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma.

Authors:  L Li; Y H Zhu; Y Li; X Y Guan
Journal:  Neoplasma       Date:  2017       Impact factor: 2.575

Review 5.  Chemokines in cancer.

Authors:  Melvyn T Chow; Andrew D Luster
Journal:  Cancer Immunol Res       Date:  2014-12       Impact factor: 11.151

6.  Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.

Authors:  Bernhard Mlecnik; Marie Tosolini; Pornpimol Charoentong; Amos Kirilovsky; Gabriela Bindea; Anne Berger; Matthieu Camus; Mélanie Gillard; Patrick Bruneval; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

7.  In situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-β secreting DCs is crucial for their enrichment and suppression in tumor immunity.

Authors:  Lin Xu; Wei Xu; Zhenke Wen; Sidong Xiong
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

8.  Tumor-induced stromal reprogramming drives lymph node transformation.

Authors:  Angela Riedel; David Shorthouse; Lisa Haas; Benjamin A Hall; Jacqueline Shields
Journal:  Nat Immunol       Date:  2016-07-11       Impact factor: 25.606

9.  CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer.

Authors:  Weilong Chen; Yuanyuan Qin; Dong Wang; Lei Zhou; Yin Liu; Sheng Chen; Liang Yin; Yaoxing Xiao; Xiao-Hong Yao; Xiaoli Yang; Wei Ma; Weifeng Chen; Xueyan He; Lixing Zhang; Qifeng Yang; Xiuwu Bian; Zhi-Ming Shao; Suling Liu
Journal:  PLoS Biol       Date:  2018-07-27       Impact factor: 8.029

10.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

View more
  51 in total

Review 1.  Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment.

Authors:  Peipei Yang; Jie Ding; Yibo Bian; Zhonghua Ma; Keming Wang; Juan Li
Journal:  Med Oncol       Date:  2022-05-17       Impact factor: 3.064

Review 2.  Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.

Authors:  Rui Qin; Weihong Ren; Guoqi Ya; Bei Wang; Jiao He; Shaoxin Ren; Lu Jiang; Shuo Zhao
Journal:  Clin Exp Med       Date:  2022-09-29       Impact factor: 5.057

3.  Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression.

Authors:  Feng Tang; Chao Yang; Feng-Ping Li; Dong-Hu Yu; Zhi-Yong Pan; Ze-Fen Wang; Zhi-Qiang Li
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-04       Impact factor: 10.183

Review 4.  Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).

Authors:  Shuyue Yang; Jiaxin Wang; Shidong Wang; Anni Zhou; Guiping Zhao; Peng Li
Journal:  Int J Oncol       Date:  2022-06-08       Impact factor: 5.884

5.  SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer.

Authors:  Siyuan Weng; Zaoqu Liu; Xiaofeng Ren; Hui Xu; Xiaoyong Ge; Yuqing Ren; Yuyuan Zhang; Qin Dang; Long Liu; Chunguang Guo; Richard Beatson; Jinhai Deng; Xinwei Han
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

6.  Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma.

Authors:  Fan Guo; Wei-Na Kong; De-Wei Li; Gang Zhao; Hui-Li Wu; Miyessar Anwar; Xiao-Qian Shang; Qian-Nan Sun; Cai-Ling Ma; Xiu-Min Ma
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 7.  Spatial determinants of CD8+ T cell differentiation in cancer.

Authors:  Katherine A Tooley; Giulia Escobar; Ana C Anderson
Journal:  Trends Cancer       Date:  2022-05-05

8.  Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity.

Authors:  Caleb R Stoltzfus; Ramya Sivakumar; Leo Kunz; Brandy E Olin Pope; Elena Menietti; Dario Speziale; Roberto Adelfio; Marina Bacac; Sara Colombetti; Mario Perro; Michael Y Gerner
Journal:  Front Immunol       Date:  2021-08-05       Impact factor: 7.561

Review 9.  B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments.

Authors:  Yuan Wei; Chun-Xiang Huang; Xiao Xiao; Dong-Ping Chen; Hong Shan; Huanhuan He; Dong-Ming Kuang
Journal:  Oncogene       Date:  2021-06-29       Impact factor: 9.867

Review 10.  Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers.

Authors:  Linda A Schuler; Fern E Murdoch
Journal:  Cancers (Basel)       Date:  2021-07-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.